Broadwind (BWEN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Special Meeting scheduled for October 23, 2024, to ratify the increase in authorized common stock from 30,000,000 to 45,000,000 and to approve potential adjournments to solicit additional votes or establish a quorum.
Ratification is intended to resolve uncertainty and mitigate litigation risk following stockholder challenges regarding broker voting authority and vote tabulation at the 2024 Annual Meeting.
The Board unanimously recommends voting in favor of both the Ratification and Adjournment proposals.
No dilution of current ownership or change in outstanding shares will result from the Ratification; it only confirms prior approvals.
Voting matters and shareholder proposals
Proposal 1: Ratification of the amendment increasing authorized common stock to 45,000,000 shares, retroactive to May 16, 2024.
Proposal 2: Approval of adjournments of the Special Meeting if needed to solicit more votes or establish a quorum.
Failure to approve Ratification could expose the company to claims regarding the validity of the amendment and limit future equity issuances.
No appraisal or dissenters' rights are available for these proposals.
Stockholder proposals for the 2025 Annual Meeting must be received by December 3, 2024, for inclusion in the proxy statement.
Board of directors and corporate governance
The Board adopted resolutions on July 22, 2024, to ratify the amendment and recommend stockholder approval.
The Board may abandon the ratification at any time before the validation effective time, even after stockholder approval.
The Board has authorized the retention of a proxy solicitor and payment of related fees.
Latest events from Broadwind
- Q4 2025 revenue up 12.4% year-over-year, record backlog, and 2026 guidance targets 20%+ growth.BWEN
Q4 202511 Mar 2026 - Q2 revenue dropped 28% year-over-year, but cost actions and guidance signal a late-2024 wind recovery.BWEN
Q2 20241 Feb 2026 - Revenue and profit fell, but orders surged 45%, supporting a strong backlog and recovery outlook.BWEN
Q3 202414 Jan 2026 - Q4 orders surged 85% YoY; 2025 guidance targets $140–160M revenue, $13–15M EBITDA.BWEN
Q4 202426 Dec 2025 - Annual meeting covers director elections, say-on-pay, rights plan extension, and auditor ratification.BWEN
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, executive pay, tax asset protection, and auditor ratification.BWEN
Proxy Filing2 Dec 2025 - Stockholders are asked to ratify a share increase to 45 million, ensuring legal certainty.BWEN
Proxy Filing2 Dec 2025 - Share count corrections confirm 22.5M shares outstanding; major holders updated.BWEN
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, executive pay, Rights Plan, and auditor ratification.BWEN
Proxy Filing2 Dec 2025